Page last updated: 2024-11-02

pd 98059 and Depressive Disorder

pd 98059 has been researched along with Depressive Disorder in 3 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M1
He, G1
Li, Q1
Ko, MC1
Hung, YH1
Ho, PY1
Yang, YL1
Lu, KT1
Epstein, OI1
Vorobieva, OV1
Grinkevich, LN1
Kharchenko, OA1
Shtark, MB1

Other Studies

3 other studies available for pd 98059 and Depressive Disorder

ArticleYear
Maternal deprivation promotes hippocampal neuronal apoptosis via ERK1/2 signaling.
    Frontiers in bioscience (Landmark edition), 2018, 06-01, Volume: 23, Issue:10

    Topics: Animals; Animals, Newborn; Apoptosis; Apoptosis Regulatory Proteins; Depressive Disorder; Female; Fl

2018
Neonatal glucocorticoid treatment increased depression-like behaviour in adult rats.
    The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:12

    Topics: Amygdala; Animals; Animals, Newborn; Antidepressive Agents; Depressive Disorder; Dose-Response Relat

2014
Psychotropic drug tenoten activates mitogen-activated MAP/ERK kinase regulatory cascade controlling the neuroprotective effects.
    Bulletin of experimental biology and medicine, 2007, Volume: 144, Issue:3

    Topics: Animals; Antibodies; Anxiety; Depressive Disorder; Enzyme Activation; Enzyme Inhibitors; Extracellul

2007